Evaluation indicators | Scope of application | ||
---|---|---|---|
Province | City | County | |
A. Integrated support capability | √ | √ | √ |
A1. Fund | √ | √ | √ |
A11. Proportion of fiscal appropriations to annual expenditures | √ | √ | √ |
A12. Growth rate of annual government funding | √ | √ | √ |
A2. Talent team construction | √ | √ | √ |
A21. Proportion of healthcare technicians | √ | √ | √ |
A22. Proportion of professional technicians | √ | √ | √ |
A23. Proportion of highly educated technicians | √ | √ | |
A3. Infrastructure, materials, and equipment | √ | √ | √ |
A31. Compliance rate of inspection equipment | √ | √ | √ |
A32. Informatization construction evaluation index | √ | ||
A4. Laboratory capacity and safety | √ | √ | √ |
A41. Implementation rate of laboratory testing programs | √ | √ | √ |
A42. Laboratory safety management | √ | √ | √ |
A43. Laboratory quality control coverage | √ | √ | √ |
A44. Class III biosafety lab | √ | ||
A5. Party construction | √ | √ | √ |
A51. Implementation of the party construction work responsibility system | √ | √ | √ |
B. Communicable disease prevention and control | √ | √ | √ |
B1. Overview of infectious disease prevention and control | √ | √ | √ |
B11. Comprehensive evaluation rate of information quality in epidemic reporting | √ | √ | √ |
B12. Statutory infectious disease reporting rate in medical institutions | √ | √ | |
B13. Infectious disease surveillance integrity rate | √ | √ | √ |
B14. Outbreak standardized disposal index | √ | √ | |
B15. Coverage rate of direct network reporting of infectious diseases | √ | √ | |
B16. Timely response rate of automatic warning signals for infectious diseases | √ | √ | √ |
B17. Priority infectious disease surveillance integrity rate | √ | √ | |
B18. Experimental diagnosis rate of priority infectious diseases | √ | √ | √ |
B19. Laboratory testing capacity for priority infectious diseases | √ | √ | √ |
B110. Incidence of AFP cases in children under 15 years old | √ | √ | √ |
B111. Severe respiratory syndrome monitoring | √ | √ | |
B2. AIDS and syphilis prevention and control | √ | √ | |
B21. Coverage of interventions for high-risk groups of AIDS | √ | √ | |
B22. Proportion of HIV-infected and AIDS patients followed up with interventions | √ | √ | |
B23. Accuracy of syphilis epidemic reporting | √ | √ | |
B24. Consultation and testing rate for syphilis in high-risk populations | √ | √ | |
B3. Tuberculosis prevention and control | √ | √ | √ |
B31. Incidence of tuberculosis | √ | √ | √ |
B32. Management rate of tuberculosis patients | √ | √ | √ |
B33. Supervisory coverage of tuberculosis control | √ | √ | |
B4. Surveillance of insect-borne infectious diseases | √ | √ | √ |
B41. Completion rate of vector monitoring | √ | √ | √ |
B5. Endemic disease | √ | √ | √ |
B51. Completion rate of endemic disease monitoring | √ | √ | √ |
B6. Immunization planning and vaccine management | √ | √ | √ |
B61. Childhood vaccination rate | √ | √ | √ |
B62. Standardized treatment rate of suspected abnormal reactions to vaccination | √ | √ | √ |
B63. Children’s vaccination certification rate | √ | √ | |
B64. Coverage of full electronic vaccine tracing | √ | √ | √ |
B65. Monitoring completion rate for vaccine-preventable infectious diseases | √ | √ | √ |
B66. Coverage rate of standardized vaccination clinics | √ | √ | √ |
C. Chronic non-communicable disease prevention and control | √ | √ | √ |
C1. Overview of chronic non-communicable disease prevention and control | √ | √ | √ |
C11. Coverage rate of whole-population cause-of-death monitoring | √ | √ | |
C12. Standardized registration and reporting rate of causes of death | √ | √ | √ |
C13. Target achievement rate of the National Healthy Lifestyle | √ | ||
C2. Monitoring of risk factors for chronic non-communicable diseases | √ | √ | |
C21. Coverage rate of monitoring chronic disease risk factors | √ | √ | |
D. Public health emergency response | √ | √ | √ |
D1. Emergency disposal | √ | √ | √ |
D11. Regulated disposal index | √ | √ | √ |
D12. Timely incident reporting rate | √ | √ | √ |
D13. Information direct network reporting rate | √ | √ | √ |
D14. Emergency stockpile completeness rate | √ | √ | √ |
E. Health hazard monitoring and control | √ | √ | √ |
E1. Monitoring and control of occupational disease hazards | √ | √ | √ |
E11. Completion rate of priority occupational disease monitoring | √ | √ | √ |
E12. Occupational health monitoring rate | √ | √ | √ |
E2. Foodborne disease prevention and control | √ | √ | √ |
E21. Completion rate of food safety risk monitoring | √ | √ | √ |
E3. Environmental hazards control | √ | √ | √ |
E31. Drinking water monitoring rate | √ | √ | √ |
F. Health education and promotion | √ | √ | |
F1. Health education for target groups | √ | √ | |
F11. Behavioral intervention index for target groups | √ | ||
F12. Awareness rate of key hygiene and disease prevention knowledge among target groups | √ | √ | |
F13. Awareness rate of blood pressure and blood glucose in the population | √ | √ | |
G. Information management | √ | √ | |
G1. Information utilization and analysis | √ | √ | |
G11. Evaluation index for data analysis | √ | √ | |
H. Skill and technical guidance | √ | √ | √ |
H1. Skill training | √ | √ | √ |
H11. Job skill training rate | √ | √ | √ |
H2. Technical guidance | √ | √ | √ |
H21. Coverage rate of grassroots professional guidance | √ | √ | √ |
H22. Per capita days of professional guidance at the grassroots | √ | √ | √ |
I. Integrated service indicators | √ | √ | √ |
I1. Other work capacities | √ | √ | √ |
I11. Completion rate of directive work | √ | √ | √ |
I12. Comprehensive evaluation of abilities and qualifications | √ | √ | √ |
I13. Project budget completion rate | √ | √ | √ |
J. Outcome of disease prevention and control | √ | √ | √ |
J1. Outcome indicators for communicable disease prevention and control | √ | √ | √ |
J11. Disability rate in newly discovered leprosy patients | √ | √ | √ |
J12. Achievement rate of parasitic disease prevention and control goals | √ | √ | √ |
J13. Compliance rate for communicable diseases under planning control | √ | √ | √ |
J14. Mortality rate for statutory infectious diseases | √ | √ | √ |
K. Institutional development and satisfaction evaluation | √ | √ | √ |
K1. Scientific research capacity | √ | √ | |
K11. Comprehensive evaluation of scientific research projects | √ | √ | |
K2. Satisfaction evaluation | √ | √ | √ |
K21. Employee satisfaction | √ | √ | √ |
K22. Public satisfaction | √ | √ | √ |